Home > Product > APIs > Felypressin Acetate


Felypressin Acetate

Price Inquiry
Octapressin; Octopressin; Phelypressin; Phenylalanine Lysine Vasopressin; PLV-2; Vasopressin, Phenylalanyl-Lysyl
H-Cys-Phe-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 acetate salt (Disulfide bond)
Molecular Formula
Long-term Storage Conditions
Felypressin is a non-catecholamine vasoconstrictor that is chemically related to vasopressin, the posterior pituitary hormone. It is added to some local anaesthetics.
Felypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As. It physiologically effects on vascular SMC's due to the form in which it is administered. Its receptors are found in various sites around the body. The major points include the CNS, Liver, Anterior Pituitary, Muscle (both vascular and non-vascular smooth muscle), and Platelets (CLAMP).
Areas of Interest
Vasoconstrictor & Anaesthetic
  • Background
  • Related Products
  • References

Felypressin, a synthetic analogue of vasopressin (AVP), has been widely used as a substitute for epinephrine (EPI) in anesthetic solutions to promote local vasoconstriction during medical and dental practices. Because it has no interaction with adrenergic receptors, it is suggested that felypressin has fewer side effects than EPI. Hence, Felypressin causes fewer cardiovascular and metabolic side effects, and it has a higher median lethal dose (LD50) than EPI. However, the mechanisms and the receptors used by felypressin to induce cardiovascular effects are unknown, and very few studies have been conducted on its possible systemic effects.

CAS: 33125-97-2 (net)
Sequence: ---
M.W: 244.29
Molecular Formula: C14H16N2O2
CAS: 2078-54-8
Sequence: ---
M.W: 178.2707
Molecular Formula: C12H18O
CAS: 107452-89-1
Sequence: Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr-Asp-Cys-Cys -Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-Cys-NH2 (Disulfide,Cys1-Cys16, Cys8-Cys20,Cys15-Cys25)
M.W: 2639.2
Molecular Formula: C102H172N36O32S7

Cardiovascular effects of felypressin (FEL) were studied in Wistar rats. Heart rate and mean arterial pressure measurements were taken in awake rats treated with vasopressin (AVP), FEL, or epinephrine (EPI). Each group received either an intravenous (IV) or an intracerebroventricular V1 receptor antagonist, saline, area postrema removal, or sham surgery. Analysis of variance and Student-Newman-Keuls (P < .05) were applied. Felypressin and AVP induced a pressor effect, and bradycardia was inhibited by IV V1 antagonist. Intracerebroventricular V1 antagonist and area postrema removal enhanced their pressor effects. Epinephrine induced a higher pressor effect and a similar bradycardia that was not affected by the treatments. It was concluded that FEL depends on V1 receptors to induce pressor and bradycardic effects, and that it produces a high relationship between bradycardia and mean arterial pressure variation depending on area postrema and central V1 receptors. These effects are potentially less harmful to the cardiovascular system than the effects of EPI.

Cecanho, R., De Luca Jr, L. A., & Ranali, J. (2006). Cardiovascular effects of felypressin. Anesthesia progress, 53(4), 119-125.

Online Inquiry

Name (First Last) *
Email *
Phone *
Service & Products of Interest *
Services Required and Project Description
Verification code *Please enter the code "peptides"
Home | Site Map | Contact Us | Resources
Copyright © 2008 - Creative Peptides. All rights reserved.